SCHEMBL8153199

SCHEMBL8153199

COC(=O)c1ccc(Cl)nc1.Nc1nc(N)nc(-c2ccc(Cl)nc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
L3MBTL1 Q9Y468 3/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 2/20 0.44
NAPRT Q6XQN6 1/20 0.43
RAB9A P51151 3/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
PKM P14618 1/20 0.42
DHFR P00374 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 1/20 0.41
NPC1 O15118 2/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
ROCK1 Q13464 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64640 0.83 MAPK1 (0.65) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL29552438 0.83 MAPK1 (0.65) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL29776105 0.81 MAPK1 (0.62) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL20241211 0.81 MAPK1 (0.62) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL6984646 0.81 RAB9A (0.59) KDM4ENAPRTRAB9APOLBDHFR
SCHEMBL38659193 0.80 KDM4E (0.50) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL2952147 0.80 KDM4E (0.50) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL1945357 0.78 KDM4E (0.42) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA
SCHEMBL117753 0.73 KDM4E (0.41) MAPK1SMN1; SMN2L3MBTL1KDM4ERAB9A
SCHEMBL23796888 0.72 NAPRT (0.55) MAPK1SMN1; SMN2L3MBTL1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed